BR9708964A - Fragmento isolado de dna veículo de expressão vetor de expressão célular recombinante utilizacão de sequências e processo de produção de proteínas - Google Patents

Fragmento isolado de dna veículo de expressão vetor de expressão célular recombinante utilizacão de sequências e processo de produção de proteínas

Info

Publication number
BR9708964A
BR9708964A BR9708964A BR9708964A BR9708964A BR 9708964 A BR9708964 A BR 9708964A BR 9708964 A BR9708964 A BR 9708964A BR 9708964 A BR9708964 A BR 9708964A BR 9708964 A BR9708964 A BR 9708964A
Authority
BR
Brazil
Prior art keywords
sequences
expression
production process
recombinant cell
protein production
Prior art date
Application number
BR9708964A
Other languages
English (en)
Inventor
Jacques Mallet
Rolando Meloni
Philippe Ravassard
Fabienne Treilhou
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of BR9708964A publication Critical patent/BR9708964A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

FRAGMENTO ISOLADO DE DNA, VEìCULO DE EXPRESSãO, VETOR DE EXPRESSãO, CéLULA RECOMBINANTE, UTILIZAçãO DE SEQUêNCIAS E PROCESSO DE PRODUçãO DE PROTEìNAS. A presente invenção refere-se a um novo sistema de expressão de genes. O sistema da invenção é baseado notadamente na utilização de sequências derivadas do primeiro íntron do gene da tirosina hidroxilase possuindo propriedades de realçador da transcrição. O sistema da invenção é particularmente vantajoso para a produção de proteínas in vitro, ex vivo ou in vivo, notadamente em aplicações de terapia gênica.
BR9708964A 1996-04-25 1997-04-10 Fragmento isolado de dna veículo de expressão vetor de expressão célular recombinante utilizacão de sequências e processo de produção de proteínas BR9708964A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9605223A FR2748032B1 (fr) 1996-04-25 1996-04-25 Systeme d'expression derive du gene de la tyrosine hydroxylase
PCT/FR1997/000636 WO1997040172A1 (fr) 1996-04-25 1997-04-10 Systeme d'expression derive du gene de la tyrosine hydroxylase

Publications (1)

Publication Number Publication Date
BR9708964A true BR9708964A (pt) 1999-08-03

Family

ID=9491582

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9708964A BR9708964A (pt) 1996-04-25 1997-04-10 Fragmento isolado de dna veículo de expressão vetor de expressão célular recombinante utilizacão de sequências e processo de produção de proteínas

Country Status (14)

Country Link
US (1) US6432701B1 (pt)
EP (1) EP0895542A1 (pt)
JP (1) JP2000508904A (pt)
KR (1) KR20000010608A (pt)
AU (1) AU722960B2 (pt)
BR (1) BR9708964A (pt)
CA (1) CA2252529A1 (pt)
FR (1) FR2748032B1 (pt)
HU (1) HUP9902298A3 (pt)
IL (1) IL126719A0 (pt)
NO (1) NO984879D0 (pt)
SK (1) SK146998A3 (pt)
WO (1) WO1997040172A1 (pt)
ZA (1) ZA973510B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19928342A1 (de) * 1999-06-21 2000-12-28 Deutsches Krebsforsch Vektoren zur gentherapeutischen Tumorbehandlung
US7195910B2 (en) 2000-08-30 2007-03-27 Thomas Jefferson University Human tyrosine hydroxylase promoter and uses thereof
WO2002018548A2 (en) * 2000-08-30 2002-03-07 Thomas Jefferson University Tyrosine hydroxylase 5' control elements and uses thereof

Also Published As

Publication number Publication date
NO984879L (no) 1998-10-19
ZA973510B (en) 1997-11-18
US6432701B1 (en) 2002-08-13
KR20000010608A (ko) 2000-02-15
FR2748032A1 (fr) 1997-10-31
WO1997040172A1 (fr) 1997-10-30
CA2252529A1 (fr) 1997-10-30
EP0895542A1 (fr) 1999-02-10
SK146998A3 (en) 1999-04-13
FR2748032B1 (fr) 1998-05-22
AU2641097A (en) 1997-11-12
NO984879D0 (no) 1998-10-19
IL126719A0 (en) 1999-08-17
HUP9902298A2 (hu) 1999-11-29
JP2000508904A (ja) 2000-07-18
HUP9902298A3 (en) 2000-03-28
AU722960B2 (en) 2000-08-17

Similar Documents

Publication Publication Date Title
Koike et al. Purification, structure, and biochemical properties of human O6-methylguanine-DNA methyltransferase.
Yalamanchili et al. Cleavage of transcriptional activator Oct-1 by poliovirus encoded protease 3Cpro
Saxena et al. Ribozymes correctly cleave a model substrate and endogenous RNA in vivo.
Janke et al. Polyglutamylation: a fine‐regulator of protein function?
Daga et al. Molecular characterization of the transcription termination factor from human mitochondria.
Myllyharju et al. Identification of a novel proline‐rich peptide‐binding domain in prolyl 4‐hydroxylase
Zühl et al. Subunit topology of the Rhodococcus proteasome
BRPI9913360B8 (pt) proteína de uricase recombinante quimérica, molécula de ácido nucléico isolada e purificada, vetor e célula hospedeira transformada.
BRPI0014115B8 (pt) métodos de produzir um panto-composto, pantotenato e beta-alanina, de aumentar a produção de um panto-composto e de edentificar compostos que modulam a atividade da pantotenato cinase, micro-organismo recombinante, vetor recombinante, e, vetor
SG141233A1 (en) Control of gene expression
Williams et al. Structural changes in the T4 gene 32 protein induced by DNA polynucleotides.
ATE417927T1 (de) Neue knochenmineralisierungsproteine, dna, vektoren, expressionssysteme
BR9913331A (pt) Expressão e exportação de inibidores de angiogênese como imunofusinas
HUP9900018A1 (hu) Cirkuláris DNS-molekula feltételes replikációs origóval, eljárás előállítására és génterápiában való felhasználására
DE69524740D1 (de) Thymidin-kinase-mutanten
ATE315087T1 (de) Neuartige auf p53 ansprechende gene
Rosas et al. Methylation status in the promoter region of the human PGP9. 5 gene in cancer and normal tissues
AUPP472398A0 (en) Protease susceptibility II
BR9708964A (pt) Fragmento isolado de dna veículo de expressão vetor de expressão célular recombinante utilizacão de sequências e processo de produção de proteínas
Panganiban et al. Purification and properties of a new bacillus subtilis RNA processing enzyme. Cleavage of phage SP82 mRNA and Bacillus subtilis precursor rRNA.
Monsalve et al. Binding of phage φ29 protein p4 to the early A2c promoter: recruitment of a repressor by the RNA polymerase
DE69736673D1 (en) Rifamycin biosynthese genkluster
Reddy et al. Nucleotides sequence of the genes for the simian virus 40 proteins VP2 and VP3.
Meinnel et al. Binding of the anticodon domain of tRNAfMet to Escherichia coli methionyl-tRNA synthetase
Tang et al. Nerve growth factor mRNA stability is controlled by a cis-acting instability determinant in the 3′-untranslated region

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A, 7A, 8A E 9A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1872 DE 21/11/2006.